Medical Health & Life Science Research News

Global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020 available in new report

Global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020 available in new report

The report covers the present scenario and the growth prospects of the global monoclonal antibody (mAb) biosimilars market 2016-2020.

- Advertising -

About Biosimilars

Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule.

Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product.

- Advertising -

Request Sample At: www.researchbeam.com/global-mab-bi…-2016-2020-market

Research Beam analysts forecast the spending on the global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020.

Covered in this report

To calculate the market size, the report considers the report considers the revenue generated from the sales of mAbs. The report also considers the revenues generated from the sales of drugs that are expected to be launched during the forecast period.

The market is divided into the following segments based on geography:

  • Europe
  • Asia
  • ROW

Enquire About Report At: www.researchbeam.com/global-mab-bi…uire-about-report

Market challenge

  • Physicians' reluctance to prescribe biosimilars
  • For a full, detailed list, view our report

Market trend

  • Emergence of biosimilars
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table Of Contents:

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings
  • Assumptions

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Biosimilars: Overview
  • Comparative analysis of generic small molecules and biosimilars
  • Biosimilars market opportunities
  • Challenges for new entrants
  • Bio-betters

PART 05: Pipeline portfolio

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by application

  • Global chronic and autoimmune diseases mAb biosimilars market
  • Global oncology mAb biosimilars market

PART 08: Geographical segmentation

  • Global mAb biosimilars market by geographical segmentation 2015-2020
  • mAb biosimilars market in Europe
  • mAb biosimilars market in Asia
  • mAb biosimilars market in rest of the world

PART 09: Market drivers

  • Rise in number of patent expiries
  • Need for cost-effective treatment
  • Reimbursement benefits for biosimilars
  • Favorable government regulations

PART 10: Impact of drivers

News From

Research Beam - precise market researchResearch Beam
Category: Market Research Publishers and RetailersCompany profile: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports fro ...